• Mashup Score: 2

    Chronic inflammation is a major cause of cancer worldwide. Interleukin 33 (IL-33) is a critical initiator of cancer-prone chronic inflammation; however, its induction mechanism by the environmental causes of chronic inflammation is unknown. Herein, we demonstrate that Toll-like receptor (TLR)3/4-…

    Tweet Tweets with this article
    • Preprint on inflammation-cancer axis via @researchsquare: In preclinical models, statins prevent development of #PancreaticCancer in chronic inflammation by blocking interleukin 33 (IL-33) expression induced via TBK1-IRF3 signaling. https://t.co/oFd65x5d3g